PORSHIA MAHORO: Open Payments
NPI 1255855540 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 40 payments from 18 companies in 2025. Trend: 2023 $982 · 2024 $586 · 2025 $832
Food & beverage: $832
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $93 |
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Janssen Biotech, Inc. | 3 | $61 |
| Syndax Pharmaceuticals, Inc. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Celgene Corporation | 2 | $55 |
| Lilly USA, LLC | 2 | $42 |
| ARRAY BIOPHARMA INC | 2 | $40 |
Products named: IMFINZI, OJJAARA, OPDIVO, REBLOZYL, NINLARO, VERZENIO, Enhertu, BRAFTOVI.
Industry payments across TN — which companies pay providers there.
